Musely secures $360M from General Catalyst without giving up equity

Musely, a direct-to-consumer telemedicine platform specializing in compounded treatments for skin, hair, and menopause care, secured $360M from General Catalyst's Customer Value Fund (CVF). The novel financing uses a revenue-share model instead of equity dilution, appealing to the cash-flow-positive company seeking to maintain ownership. This demonstrates growing interest in alternative financing mechanisms for capital-efficient, revenue-generating businesses.